Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced preliminary in ...
ARTBIO, Inc. ("ARTBIO"), a clinical-stage radiopharmaceutical company developing a new class of 212Pb alpha radioligand therapies (ARTs), announced the appointment of Jonathan Freeman, Ph.D. as Chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback